Last 48 quarters of trend data · Healthcare · Healthcare Providers
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 13.37 | 18.05 | 13.79 | 25.64 | 10.45 | 14.01 | 18.31 | 23.94 | 94.33 | 28.03 | 29.83 | 80.33 | 23.67 | 56.68 | 37.39 | 53.15 | 34.04 | 17.55 | 47.96 | 60.14 | 31.21 |
| — | +28.9% | -24.7% | +7.1% | -88.9% | -50.0% | -38.6% | -70.2% | +298.5% | -50.6% | -20.2% | +51.1% | -30.5% | +223.0% | -22.0% | -11.6% | +9.1% | -37.8% | +15.4% | +82.6% | -39.9% | |
| P/S Ratio | 0.58 | 0.59 | 0.63 | 0.67 | 0.67 | 0.79 | 0.87 | 0.75 | 1.31 | 1.31 | 1.18 | 1.20 | 0.92 | 0.96 | 1.09 | 0.99 | 0.96 | 0.81 | 1.54 | 2.17 | 1.55 |
| — | -24.6% | -28.3% | -10.1% | -48.6% | -40.0% | -25.6% | -37.5% | +42.2% | +36.8% | +7.7% | +20.4% | -4.2% | +18.9% | -29.0% | -54.2% | -38.1% | -53.8% | -28.0% | +11.7% | -26.0% | |
| P/B Ratio | 0.86 | 0.85 | 0.90 | 0.87 | 0.95 | 1.11 | 1.17 | 0.94 | 1.69 | 1.69 | 1.48 | 1.50 | 1.24 | 1.23 | 1.41 | 1.23 | 1.24 | 0.98 | 1.89 | 2.72 | 2.06 |
| — | -23.0% | -23.0% | -7.2% | -43.4% | -34.5% | -20.7% | -37.0% | +36.3% | +37.6% | +4.6% | +21.7% | -0.3% | +24.8% | -25.5% | -54.8% | -39.8% | -57.4% | -34.3% | +9.5% | -31.1% | |
| P/FCF | 6.33 | 5.24 | 4.92 | 84.31 | 6.04 | 7.01 | 6.75 | 214.08 | 11.24 | 7.63 | 19.79 | — | 9.77 | 7.61 | 6.18 | 6643.04 | 12.93 | 8.28 | 12.62 | — | 17.87 |
| — | -25.2% | -27.2% | -60.6% | -46.3% | -8.2% | -65.9% | — | +15.0% | +0.3% | +220.2% | — | -24.4% | -8.1% | -51.0% | — | -27.6% | -47.0% | -2.6% | — | -46.1% | |
| EV / EBITDA | 6.85 | 13.44 | 6.66 | 6.62 | 6.18 | 7.16 | 8.47 | 7.85 | 10.39 | 10.51 | 10.19 | 11.05 | 8.49 | 9.76 | 10.35 | 11.00 | 9.18 | 7.48 | 13.73 | 16.85 | 11.46 |
| — | +87.7% | -21.3% | -15.7% | -40.5% | -31.9% | -16.9% | -29.0% | +22.3% | +7.7% | -1.6% | +0.5% | -7.5% | +30.5% | -24.6% | -34.7% | -19.9% | -36.4% | -7.4% | +30.4% | -0.7% | |
| EV / EBIT | 11.21 | 13.44 | 11.86 | 18.46 | 9.39 | 12.41 | 14.58 | 17.60 | 32.48 | 18.17 | 18.68 | 32.04 | 15.95 | 21.76 | 21.50 | 28.16 | 20.64 | 14.93 | 29.63 | 35.70 | 21.28 |
| — | +8.3% | -18.7% | +4.9% | -71.1% | -31.7% | -21.9% | -45.1% | +103.6% | -16.5% | -13.1% | +13.8% | -22.7% | +45.7% | -27.5% | -21.1% | -3.0% | -27.2% | +6.9% | +56.9% | -15.9% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 25.6% | 25.8% | 27.0% | 25.6% | 27.4% | 25.4% | 25.3% | 24.3% | 25.0% | 24.1% | 24.5% | 24.8% | 27.1% | 24.9% | 24.8% | 24.4% | 27.0% | 24.4% | 26.2% | 25.8% | 28.4% |
| — | +1.6% | +6.3% | +5.4% | +9.6% | +5.6% | +3.6% | -2.4% | -7.7% | -3.3% | -1.4% | +1.7% | +0.3% | +2.0% | -5.3% | -5.4% | -5.0% | -14.5% | -11.9% | -10.0% | -7.4% | |
| Operating Margin | 9.3% | 7.6% | 9.6% | 8.1% | 10.8% | 10.3% | 8.2% | 7.8% | 7.8% | 9.7% | 8.9% | 5.2% | 8.6% | 6.6% | 7.4% | 5.5% | 7.0% | 9.3% | 7.2% | 7.6% | 9.7% |
| — | -26.1% | +16.4% | +4.1% | +38.0% | +5.7% | -7.7% | +50.2% | -8.5% | +48.1% | +20.5% | -6.2% | +21.7% | -29.1% | +3.4% | -27.4% | -27.1% | -18.6% | -27.1% | -32.1% | -7.9% | |
| Net Margin | 5.0% | 3.2% | 4.5% | 2.5% | 6.5% | 5.6% | 4.7% | 3.1% | 1.3% | 4.5% | 3.9% | 1.5% | 3.8% | 1.7% | 2.9% | 1.8% | 2.8% | 4.5% | 3.1% | 3.5% | 4.9% |
| — | -42.5% | -4.4% | -17.7% | +390.4% | +25.7% | +19.8% | +106.3% | -65.1% | +163.0% | +35.2% | -17.8% | +35.6% | -62.3% | -6.2% | -47.2% | -43.6% | -26.6% | -38.9% | -41.5% | +22.2% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 6.5% | 1.2% | 1.6% | 0.8% | 2.3% | 1.9% | 1.5% | 1.0% | 0.4% | 1.4% | 1.2% | 0.5% | 1.2% | 0.6% | 0.9% | 0.6% | 0.9% | 1.4% | 1.0% | 1.1% | 1.7% |
| — | -39.8% | +4.3% | -14.7% | +430.0% | +37.0% | +22.4% | +104.2% | -64.8% | +156.9% | +32.8% | -15.5% | +44.0% | -61.3% | -5.4% | -49.2% | -48.3% | -31.2% | -41.6% | -43.4% | +17.6% | |
| ROA | 3.0% | 0.5% | 0.7% | 0.4% | 1.1% | 0.9% | 0.7% | 0.5% | 0.2% | 0.6% | 0.5% | 0.2% | 0.5% | 0.2% | 0.4% | 0.2% | 0.4% | 0.6% | 0.4% | 0.5% | 0.7% |
| — | -42.4% | -1.1% | -17.5% | +422.0% | +37.8% | +28.4% | +119.4% | -62.5% | +169.6% | +37.9% | -13.9% | +44.3% | -61.5% | -4.4% | -47.0% | -44.2% | -24.4% | -37.1% | -40.7% | +22.5% | |
| ROIC | 5.6% | 1.2% | 1.5% | 1.2% | 1.8% | 1.6% | 1.2% | 1.1% | 1.2% | 1.4% | 1.2% | 0.7% | 1.2% | 0.9% | 1.0% | 0.7% | 0.9% | 1.2% | 0.9% | 1.0% | 1.3% |
| — | -25.7% | +21.8% | +5.4% | +48.3% | +17.2% | -1.5% | +57.2% | -2.8% | +51.2% | +23.6% | -0.0% | +31.8% | -26.2% | +6.6% | -27.9% | -29.7% | -19.3% | -27.4% | -32.1% | -8.8% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.76 | 0.79 | 0.81 | 0.78 | 0.76 | 0.75 | 0.77 | 0.70 | 0.70 | 0.76 | 0.78 | 0.80 | 0.81 | 0.84 | 0.88 | 0.87 | 0.86 | 0.82 | 0.88 | 0.92 | 0.95 |
| — | +5.1% | +5.3% | +11.0% | +8.3% | -0.8% | -0.8% | -12.2% | -14.3% | -9.7% | -11.4% | -8.5% | -4.8% | +2.0% | -1.0% | -5.1% | -10.2% | -16.3% | -13.6% | -6.1% | -5.1% | |
| Debt / EBITDA | 3.24 | 27.21 | 13.23 | 13.15 | 11.70 | 12.19 | 14.32 | 13.97 | 12.56 | 13.54 | 14.51 | 15.90 | 14.15 | 16.68 | 16.52 | 18.98 | 15.61 | 14.16 | 17.91 | 17.41 | 15.03 |
| — | +123.2% | -7.7% | -5.8% | -6.9% | -10.0% | -1.3% | -12.1% | -11.2% | -18.8% | -12.2% | -16.3% | -9.3% | +17.8% | -7.8% | +9.1% | +3.8% | -2.9% | +12.0% | +16.4% | +26.7% | |
| Current Ratio | 1.26 | 0.99 | 1.07 | 1.20 | 1.26 | 1.36 | 1.44 | 1.46 | 1.40 | 1.37 | 1.46 | 1.50 | 1.42 | 1.37 | 1.26 | 1.32 | 1.27 | 1.34 | 1.18 | 1.26 | 1.10 |
| — | -27.0% | -25.5% | -17.5% | -9.6% | -1.1% | -1.8% | -2.4% | -1.7% | +0.4% | +16.2% | +13.5% | +12.2% | +2.2% | +6.9% | +4.6% | +15.5% | +25.4% | +12.0% | +17.2% | -8.6% | |
| Quick Ratio | 0.92 | 0.69 | 0.75 | 0.86 | 0.92 | 1.00 | 1.08 | 1.08 | 1.03 | 1.02 | 1.09 | 1.14 | 1.07 | 1.02 | 0.91 | 0.96 | 0.91 | 0.96 | 0.85 | 0.93 | 0.82 |
| — | -31.1% | -31.2% | -20.1% | -10.9% | -2.1% | -0.4% | -5.2% | -3.1% | -0.2% | +20.0% | +18.6% | +16.8% | +6.2% | +7.1% | +3.8% | +11.8% | +22.3% | +9.2% | +15.6% | -8.0% | |
| Interest Coverage | 4.93 | 4.10 | 4.78 | 3.22 | 6.14 | 5.32 | 4.63 | 3.62 | 2.77 | 4.84 | 4.30 | 2.52 | 4.08 | 3.06 | 3.63 | 2.87 | 3.76 | 5.27 | 4.19 | 4.35 | 5.02 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying FMS stock.
Fresenius Medical Care AG & Co. KGaA's current P/E is 13.4x. The average P/E over the last 4 quarters is 17.0x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Fresenius Medical Care AG & Co. KGaA's current operating margin is 9.3%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Fresenius Medical Care AG & Co. KGaA's business trajectory between earnings reports.